Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-17-027487

Director sold 1,900 shares at an average $20.21 ($38,406)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Woiwode Thomas Director 2017-11-24 Sale −1,700 $20.21 $34,358 8,218 D
Woiwode Thomas Director 2017-11-27 Sale −200 $20.24 $4,048 8,018 D
Open-market sales · 1,900 sh · avg $20.21 · $38,406
Loading xslF345X03/doc4.xml…